Abstract
BackgroundTumor infiltrating lymphocyte (TIL) therapy has proved to be most effective in melanoma. Additionally, enhancing tumor reactivity by selective expansion of individual TIL subpopulations, screened for neoantigen reactivity, has demonstrated...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
